Overview

Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Difluprednate
Fluprednisolone
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate